CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax of $62.87 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax · last filed 2026-02-18
- 2025-12-27: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax $62.87M.
- 2024-12-28: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax $69.22M.
- 2023-12-30: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax $58.73M.
- 2022-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax $53.92M.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax |
|---|---|
| 2025-12-27 | $62.87M 10-K · filed 2026-02-18 |
| 2024-12-28 | $69.22M 10-K · filed 2026-02-18 |
| 2023-12-30 | $58.73M 10-K · filed 2026-02-18 |
| 2022-12-31 | $53.92M 10-K · filed 2025-02-19 |
| 2021-12-25 | $81.66M 10-K · filed 2023-02-22 |
| 2020-12-26 | $81.32M 10-K · filed 2022-02-16 |
| 2019-12-28 | $114.83M 10-K · filed 2021-02-17 |
| 2018-12-29 | $90.90M 10-K · filed 2020-02-11 |
| 2017-12-30 | $91.50M 10-K · filed 2019-02-13 |
| 2016-12-31 | $120.44M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |